BioSpace News Archive

Biotech Bay

CareDx Key Supporter of the National Kidney Foundation’s Annual Kidney Patient Summit

CareDx, Inc. today announced that it is sponsoring the National Kidney Foundation (NKF) Annual Kidney Patient Summit taking place on Capitol Hill on March 1-2, 2023.

March 1, 2023
·
4 min read
Novocure Announces Reimbursement of Optune® for the Treatment of Newly Diagnosed Glioblastoma in France

Novocure (NASDAQ:NVCR) today announced the reimbursement and availability of Optune together with temozolomide (TMZ) for the treatment of adult patients with newly diagnosed glioblastoma (GBM) in France.

March 1, 2023
·
6 min read
ADC Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present a company overview at the Cowen 43rd Annual Health Care Conference in Boston, MA, on Tuesday, March 7th at 2:50 p.m. ET.

March 1, 2023
·
4 min read
Business

Horizon Therapeutics plc Reports Fourth-Quarter and Full-Year 2022 Financial Results

Horizon Therapeutics plc (Nasdaq: HZNP) today announced fourth-quarter and record full-year 2022 financial results.

March 1, 2023
·
32 min read
Genetown

Relay Therapeutics to Participate in Two Upcoming Investor Conferences - March 1, 2023

Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in two fireside chats this month, at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 10:30 a.m. ET and the Barclays Global Healthcare Conference on Wednesday, March 15, 2023 at 4:05 p.m. ET.

March 1, 2023
·
1 min read
Biotech Beach

Kura Oncology to Participate in Upcoming Investor Conferences

Kura Oncology, Inc. today announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in the following events at upcoming investor conferences.

March 1, 2023
·
2 min read
Deals

Vivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from Advanced Facialdontics, LLC

Vivos Therapeutics, Inc. announced it has acquired certain U.S. and international patents, product rights, and other miscellaneous intellectual property from Advanced Facialdontics, LLC, a company holding propriety technology on certain FDA 510 cleared dental and medical devices.

March 1, 2023
·
6 min read
MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner Study

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to provide an update on significant progress made in the field of cannabis research.

March 1, 2023
·
7 min read
BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel

BioNTech SE (Nasdaq: BNTX, “BioNTech”, “the Company”) announced that the Company and the Weizmann Institute of Science (“Weizmann Institute”) signed a Memorandum of Understanding (MoU).

March 1, 2023
·
5 min read
Business

BrainsWay to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023

BrainsWay Ltd. today announced that it will report its fourth quarter and full year 2022 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, March 15, 2023.

March 1, 2023
·
2 min read